[EN] PDE9 INHIBITORS FOR TREATING TYPE 2 DIABETES, METABOKIC SYNDROME, AND CARDIOVASCULAR DISEASE<br/>[FR] INHIBITEURS DE PDE9 POUR LE TRAITEMENT DU DIABETE DE TYPE 2, DU SYNDROME METABOLIQUE ET DE MALADIES CARDIO-VASCULAIRES
申请人:PFIZER PROD INC
公开号:WO2004096811A1
公开(公告)日:2004-11-11
The invention provides compounds of Formula (I) the stereoisomers and prod rugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein A, P, J, x, and R10 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including, diabetes, including type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and/or cardiovascular disease.